[Form 4] Inuvo, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Impinj, Inc. (PI) Form 144 filing reveals an unidentified insider’s plan to sell 12,344 common shares through Charles Schwab, representing an aggregate market value of $1.98 million. The sale is slated for 08 Aug 2025 on the NASDAQ.

The shares were obtained the same day via an employee stock-option exercise. With 29.1 million shares outstanding, the proposed sale equals roughly 0.04 % of total float—too small to materially affect supply. No other insider sales occurred in the past three months, and the filer certifies awareness of no undisclosed adverse information.

Positive

• None.

Negative

• Insider intends to sell 12,344 shares (~$1.98 M), a potential—though minor—signal of profit-taking.

Insights

Securities Analyst

TL;DR: Small insider sale (~$2 M, 0.04 % of float); limited market impact but may hint at routine profit-taking.

The Form 144 discloses a modest disposition of 12,344 shares by an Impinj insider following an option exercise. At 0.04 % of outstanding shares, liquidity impact is negligible and unlikely to pressure the stock price. The absence of other recent sales and the standard representation of no undisclosed adverse information suggest this is a routine transaction rather than a bearish signal. Investors may monitor further filings for patterns, but on its own the event is neutral to valuation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Howe Richard K

(Last) (First) (Middle)

500 PRESIDENT CLINTON AVE.

SUITE 300

(Street)

LITTLE ROCK AR 72201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inuvo, Inc. [ INUV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2025		M		52,136	A	$0.0000	508,127	D
Common Stock	07/31/2025		F		24,120	D	$4.88	484,007	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	07/31/2025		M			52,136(2)	07/31/2025	07/31/2025	Common Stock	52,136	$0.0000	0.0000	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock.

2. Adjusted to reflect a 1-for-10 reverse stock split that occurred on June 10, 2025.

	/s/ Richard K. Howe	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Impinj (PI) shares are being sold under this Form 144?

The filing covers 12,344 common shares.

What is the market value of the proposed Impinj share sale?

The shares are valued at approximately $1.98 million.

When is the insider sale expected to occur?

The approximate sale date is 08/04/2025.

How large is the sale relative to Impinj’s total shares outstanding?

It equals about 0.04 % of the 29.1 million shares currently outstanding.

How were the shares being sold acquired?

They were obtained through an employee stock-option exercise on the same date as the planned sale.